CommercialAdministrativeLow impact
06.02.30f, Pharmacogenetic Testing to Determine Drug Sensitivity (Independence Administrators)
Independence Blue Cross·Pharmacy
Effective date
Mar 4, 2026
We identified it
Jun 19, 2026
Summary
Independence Administrators has reissued their pharmacogenetic testing policy (06.02.30f) to determine drug sensitivity. This is a policy reissue with no apparent changes to existing coverage or billing requirements.
Action Required
By March 4, 2026: Review the updated pharmacogenetic testing policy on the Independence Administrators website to confirm no changes to current billing practices for drug sensitivity testing. No immediate action required unless the full policy text reveals specific changes.